CIBC Private Wealth Group
INDV icon

CIBC Private Wealth Group’s Indivior Pharmaceuticals INDV Stock Holding History

CIBC Private Wealth Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$216K Buy
+6,029
New +$184K ﹤0.01% 1154

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Private Wealth Group's INDV Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Indivior Pharmaceuticals (INDV) in Q4 2025: 6,029 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings.

259 funds tracked by Wall St. Rank hold INDV as of Q4 2025.

  • CIBC Private Wealth Group held 6,029 shares of Indivior Pharmaceuticals worth $216K as of Q4 2025.
  • Indivior Pharmaceuticals was a new CIBC Private Wealth Group position in Q4 2025.
  • Indivior Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1154 holding.
  • 259 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.